Genetics of Oncogenes Flashcards

1
Q

cancer

A

Manifestation of mutations

usually of somatic origin

threshold model does not apply for cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Tumor progression

A

Normal->Hyperplatic(hyperplasia)–>Dysplastic(phenotypic differences)–> neoplasia(abnormal diffision, tumor growth)–> Metastatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does tumor progression result from?

A

Waves of mutation followed by clonal expansion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What alterations in malignant transformation lead to Increases survival and growth?

A

Self-sufficiency in growth signals

Insensitivity to growth-inhibitory signals

evasion of apoptosis

escape from immune attack

limitless replicative potential

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What alterations in malignant transformation lead to Metastasis?

A

loss of contact inhibition of growth

loss of cell-cell adhesion

ability to invade other tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What alteration in malignant transformation lead to increased mutation rate

A

breakdown in DNA repair and genomic stability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What alteration in malignant transformation lead to cancer energy supply?

A

Sustained angiogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Oncogenes

A

Normally stimulate growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Tumor suppressor

A

inhibit growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

DNA Repair

A

normally limit mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Proto-oncogenes

A

Produce proteins which promote cell growth or prevent apoptosis

Mutation and or over/mis expression causing cell growth

Usually gain of function mutation resulting in cancer

mutation in ONE copy sufficient to cause cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tumor suppressor genes

A

Produce proteins that inhibit the cell cycle preventing cell proliferation

Usually a Loss of Function mutation resulting in cancer

mutations in TWO copies required to cause cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mutator Genes

A

Mutations in DNA repair genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the difference between proto-oncogenes and oncogenes?

A

Proto-oncogenes are normal version of genes that can contribute to cancer when mutationally activated or inappropriately expressed.

Oncogenes are the mutant versions of the genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What do proto-oncogenes produce

A

proteins that regulate cell proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Burkitt lymphoma is caused by what

A

activation of myc

17
Q

Chronic Myeloid leukemia is caused by what

A

activation of abl

18
Q

Burkitt lymphoma

A

Blood malignancy

myc oncogene is fused to immunoglobulin locus

19
Q

Myc gene and role in Burkitt Lymphoma

A
  • Myc is a transcription factor important for G1/S transition
  • Level og oncogene expression is increased as myc is under the regulation of IgH promoter
    • leads to increased myc production
    • B-lymphocytes undergo rapid cell divisions resulting in malignant phenotype
20
Q

what is this an image of?

A

BCR-Able translocation in chronic myeloid leukemia

21
Q

what is this an image of?

A

The philadelphia chromosome translocation t(9;22)(q34;q11)

22
Q

Imaniteb and anticancer application

A

Is a powerful tyrosine kinase inhibitor- for Bcr-abl

Effective against the bcr-abl fusion protein which is stuck in its activated form

Binds to the active site of the fusion protein, bcr-able, and prevents its activity.

23
Q

What is this an image of?

A

Pharmaceutical application of Imaniteb

24
Q

Activation of Ras proto-oncogene

A

A GTPase involved in the major cell proliferative pathway(MAPKinase)

  • activated by binding to GTP
    • Initiates a phosphorylation cascade that activates cellular proliferation
      • quickly inactivated by intrinsic GTPase activity ( GTP->GDP)
      • Constant stimulation is needed to grow
25
Q

Oncogene activation of Ras

A
  • Ras GTP activates the growth pathway while Ras GDP is the inactive form where no growth occurs
    • Many mutations inhibit the GTPase activity that will allow Ras to stay active, even in the absence of a growth factor
      • Ex) single point mutation at Gly12 or Gln61
26
Q

Double minutes

A

Extrachromosomal fragments of DNA containing an amplified oncogene

Ex) EGFR is often amplified as double minute chromosome(seen in red in the image) in advanced gliomas which can be visualized by FISH Probes

27
Q

What is Her-2

A

Human Epidermal Growth Factor Receptor 2

28
Q

HER2+ tumors and Herceptin relationship

A

HER2+ tumors have increased HER2 receptors on the tumor

Trastuzumab is a Herceptin drug that binds to those receptors so that growth factors can not bind

results in decreased tumor cell proliferation

Only effective for HER2+